DiviDrip · CTOR

CTOR — Citius Oncology, Inc.

CTOR is Citius Oncology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.79. Market cap: $84M. Capital Quality Rank: 22/100 — Capital destroyer.

Stock snapshot

Price$0.79
Market cap$84M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)22 / 100 · Capital destroyer
ROIC (TTM)-45.4%
Shareholder buyback yield-7.12%
Altman Z-score zoneDistress

About CTOR

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Listed2024HQCranford, NJSectorHealthcareWebsitecitiusonc.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CTOR. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CTOR's current stock price?

CTOR (Citius Oncology, Inc.) is currently trading at $0.79.

Does CTOR pay a dividend?

CTOR (Citius Oncology, Inc.) does not currently pay a regular dividend.

What is CTOR's Capital Quality Rank?

CTOR has a Capital Quality Rank of 22/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CTOR in DiviDrip

Add CTOR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow